Aclarion Inc (ACON)

$3.29 +0.14 (4.44%)
Market Cap 7.63M
Revenue (ttm) 80,000.00
Net Income (ttm) -7.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,037.50%
Debt to Equity Ratio 0.00
Volume 43,292
Avg Vol 102,420
Day's Range N/A - N/A
Shares Out 2.46M
Stochastic %K 28%
Beta 1.18
Analysts Sell
Price Target $7.00

Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning inter...

Industry: Health Information Services
Sector: Healthcare
Phone: 833 275 2266
Address:
8181 Arista Place, Suite 100, Broomfield, United States
TraderJames2323
TraderJames2323 May. 13 at 5:08 PM
$ACON
0 · Reply
SA449
SA449 May. 13 at 1:31 PM
$ACON
0 · Reply
SA449
SA449 May. 13 at 12:00 AM
$ACON
0 · Reply
SA449
SA449 May. 12 at 4:52 PM
$ACON
1 · Reply
brightgreen68
brightgreen68 May. 12 at 2:25 PM
$ACON follow in the insiders, buy
0 · Reply
SA449
SA449 May. 11 at 2:20 AM
$ACON I have a feeling that something beautiful will happen in the coming days, always be optimistic.
1 · Reply
Putnik
Putnik May. 11 at 12:23 AM
$ACON we going up now! Something brewing? This shit needs to run!
0 · Reply
SA449
SA449 May. 8 at 9:25 PM
$ACON
0 · Reply
SA449
SA449 May. 8 at 9:20 PM
$ACON Great breaking news! Aclarion director William Wesemann acquires 1,562 common shares for $5,154.6
0 · Reply
Cashflow62
Cashflow62 May. 8 at 7:30 PM
$ACON Man just to get a few shares yikes nothing out there.......
0 · Reply
Latest News on ACON
Aclarion enters second commercial agreement with Weill Cornell Medicine

2026-05-05T11:37:11.000Z - 8 days ago

Aclarion enters second commercial agreement with Weill Cornell Medicine

Aclarion announces $2.5M share repurchase program

2026-04-22T13:10:35.000Z - 21 days ago

Aclarion announces $2.5M share repurchase program

Aclarion granted U.S. patent for AI-driven back pain assessment

2026-04-16T10:52:45.000Z - 27 days ago

Aclarion granted U.S. patent for AI-driven back pain assessment

Aclarion Receives Pinnacle Award for AI Innovation

Apr 14, 2026, 8:00 AM EDT - 4 weeks ago

Aclarion Receives Pinnacle Award for AI Innovation

Aclarion announces commercial agreement with Weill Cornell Medicine

2026-04-08T12:21:37.000Z - 5 weeks ago

Aclarion announces commercial agreement with Weill Cornell Medicine

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Apr 7, 2026, 8:00 AM EDT - 5 weeks ago

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Echo Lake calls on Aclarion director David Neal to resign

2026-03-24T12:25:45.000Z - 7 weeks ago

Echo Lake calls on Aclarion director David Neal to resign

Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc.

Mar 24, 2026, 8:00 AM EDT - 7 weeks ago

Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc.

Aclarion adopts limited duration stockholder rights plan

2026-03-19T13:37:04.000Z - 7 weeks ago

Aclarion adopts limited duration stockholder rights plan

Aclarion’s CEO publishes shareholder letter

2026-03-19T10:11:08.000Z - 7 weeks ago

Aclarion’s CEO publishes shareholder letter

Aclarion strengthens balance sheet, extends cash runway into 2028

2026-01-13T11:11:19.000Z - 4 months ago

Aclarion strengthens balance sheet, extends cash runway into 2028

Aclarion Inc trading resumes

2026-01-08T15:05:25.000Z - 4 months ago

Aclarion Inc trading resumes

Aclarion Inc trading halted, volatility trading pause

2026-01-08T15:00:34.000Z - 4 months ago

Aclarion Inc trading halted, volatility trading pause

Why Is Aclarion Stock (ACON) Up Today?

2026-01-08T13:03:55.000Z - 4 months ago

Why Is Aclarion Stock (ACON) Up Today?

Aclarion says first patients enrolled at two additional CLARITY trial sites

2026-01-06T11:20:12.000Z - 4 months ago

Aclarion says first patients enrolled at two additional CLARITY trial sites

Aclarion announces publication of Nociscan article in pain issue of IJSS

2025-12-04T13:15:42.000Z - 5 months ago

Aclarion announces publication of Nociscan article in pain issue of IJSS

Aclarion appoints Jason Brosniak as commercial director, Eastern U.S.

2025-12-02T13:10:19.000Z - 5 months ago

Aclarion appoints Jason Brosniak as commercial director, Eastern U.S.

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

Dec 2, 2025, 8:00 AM EST - 5 months ago

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

Oct 22, 2025, 6:00 AM EDT - 7 months ago

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

Aclarion Transcript: LD Micro Main Event XIX Investor Conference

Oct 20, 2025, 3:00 PM EDT - 7 months ago

Aclarion Transcript: LD Micro Main Event XIX Investor Conference

Aclarion to Present at the LD Micro Main Event XIX

Oct 9, 2025, 6:00 AM EDT - 7 months ago

Aclarion to Present at the LD Micro Main Event XIX

Aclarion presents on Nociscan technology at LSI Europe ’25

2025-10-01T11:25:06.000Z - 8 months ago

Aclarion presents on Nociscan technology at LSI Europe ’25

Aclarion announces first enrollment at pivotal CLARITY trial

2025-09-25T10:10:43.000Z - 8 months ago

Aclarion announces first enrollment at pivotal CLARITY trial

Aclarion names Greg Gould as CFO, effective immediately

2025-09-03T10:05:39.000Z - 9 months ago

Aclarion names Greg Gould as CFO, effective immediately

Aclarion announces first patient enrolled in Clarity trial

2025-06-25T10:05:44.000Z - 11 months ago

Aclarion announces first patient enrolled in Clarity trial

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Jun 24, 2025, 7:00 AM EDT - 11 months ago

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

May 20, 2025, 6:00 AM EDT - 1 year ago

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

May 12, 2025, 7:34 AM EDT - 1 year ago

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Apr 29, 2025, 6:00 AM EDT - 1 year ago

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Aclarion Transcript: Planet MicroCap Showcase VEGAS 2025

Apr 23, 2025, 12:00 PM EDT - 1 year ago

Aclarion Transcript: Planet MicroCap Showcase VEGAS 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Apr 23, 2025, 6:00 AM EDT - 1 year ago

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 21, 2025, 6:00 AM EDT - 1 year ago

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 9, 2025, 7:00 AM EDT - 1 year ago

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Apr 2, 2025, 6:00 AM EDT - 1 year ago

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Aclarion Provides Shareholder Update

Mar 13, 2025, 9:25 AM EDT - 1 year ago

Aclarion Provides Shareholder Update

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Mar 6, 2025, 9:35 AM EST - 1 year ago

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Aclarion Announces First Commercial Agreement with Scripps Health

Mar 3, 2025, 6:00 AM EST - 1 year ago

Aclarion Announces First Commercial Agreement with Scripps Health

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Feb 20, 2025, 6:00 AM EST - 1 year ago

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Feb 11, 2025, 7:58 AM EST - 1 year ago

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Feb 6, 2025, 7:23 AM EST - 1 year ago

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Feb 4, 2025, 7:23 AM EST - 1 year ago

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Aclarion Transcript: Investor Update

Nov 23, 2024, 7:00 AM EST - 1 year ago

Aclarion Transcript: Investor Update

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Nov 21, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Nov 14, 2024, 5:00 PM EST - 1 year ago

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Sep 27, 2024, 6:57 AM EDT - 1 year ago

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 13, 2024, 8:30 AM EDT - 1 year ago

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Sep 12, 2024, 6:57 AM EDT - 1 year ago

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Sep 10, 2024, 6:57 AM EDT - 1 year ago

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Sep 5, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aug 29, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aug 21, 2024, 7:57 AM EDT - 1 year ago

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aclarion Transcript: Investor Update

Aug 20, 2024, 4:00 AM EDT - 1 year ago

Aclarion Transcript: Investor Update

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aug 15, 2024, 9:48 AM EDT - 1 year ago

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aclarion Announces First Commercial Agreement in Michigan

Aug 14, 2024, 8:08 AM EDT - 1 year ago

Aclarion Announces First Commercial Agreement in Michigan

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Aug 13, 2024, 9:07 AM EDT - 1 year ago

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Jul 9, 2024, 7:00 AM EDT - 2 years ago

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Jun 26, 2024, 8:30 AM EDT - 2 years ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Jun 25, 2024, 8:30 AM EDT - 2 years ago

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Apr 25, 2024, 9:14 AM EDT - 2 years ago

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Aclarion Announces Closing of $3.0 Million Public Offering

Feb 27, 2024, 3:22 PM EST - 2 years ago

Aclarion Announces Closing of $3.0 Million Public Offering

Aclarion Announces Pricing of $3.0 Million Public Offering

Feb 26, 2024, 9:15 AM EST - 2 years ago

Aclarion Announces Pricing of $3.0 Million Public Offering

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Feb 5, 2024, 8:00 AM EST - 2 years ago

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Jan 22, 2024, 8:00 AM EST - 2 years ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Nov 27, 2023, 8:00 AM EST - 2 years ago

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Nov 6, 2023, 8:00 AM EST - 2 years ago

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Oct 24, 2023, 8:45 AM EDT - 2 years ago

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Oct 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Aug 25, 2023, 4:10 PM EDT - 2 years ago

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Jun 14, 2023, 11:27 AM EDT - 3 years ago

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

TraderJames2323
TraderJames2323 May. 13 at 5:08 PM
$ACON
0 · Reply
SA449
SA449 May. 13 at 1:31 PM
$ACON
0 · Reply
SA449
SA449 May. 13 at 12:00 AM
$ACON
0 · Reply
SA449
SA449 May. 12 at 4:52 PM
$ACON
1 · Reply
brightgreen68
brightgreen68 May. 12 at 2:25 PM
$ACON follow in the insiders, buy
0 · Reply
SA449
SA449 May. 11 at 2:20 AM
$ACON I have a feeling that something beautiful will happen in the coming days, always be optimistic.
1 · Reply
Putnik
Putnik May. 11 at 12:23 AM
$ACON we going up now! Something brewing? This shit needs to run!
0 · Reply
SA449
SA449 May. 8 at 9:25 PM
$ACON
0 · Reply
SA449
SA449 May. 8 at 9:20 PM
$ACON Great breaking news! Aclarion director William Wesemann acquires 1,562 common shares for $5,154.6
0 · Reply
Cashflow62
Cashflow62 May. 8 at 7:30 PM
$ACON Man just to get a few shares yikes nothing out there.......
0 · Reply
SA449
SA449 May. 8 at 3:43 PM
$ACON
0 · Reply
SA449
SA449 May. 7 at 10:57 PM
$ACON TO THE TOP
0 · Reply
SA449
SA449 May. 7 at 1:24 PM
$ACON Aclarion continues to build exceptional momentum. Expanding the CLARITY trial with leading spine innovators further strengthens the clinical validation of Nociscan and accelerates its path toward large-scale adoption in a massive market.
0 · Reply
SA449
SA449 May. 7 at 12:32 PM
$ACON
0 · Reply
Putnik
Putnik May. 6 at 9:21 PM
$ACON it’s overdue for a real fucking run! $7 to $10!
0 · Reply
SA449
SA449 May. 6 at 2:00 PM
$ACON Always Be Optimistic
0 · Reply
focafoca99
focafoca99 May. 6 at 10:15 AM
$ACON granted an inducement stock option to its new Western U.S. Commercial Director.
0 · Reply
SA449
SA449 May. 6 at 1:33 AM
$ACON
0 · Reply
BioTuesdays
BioTuesdays May. 5 at 7:45 PM
$ACON has announced the establishment of a second agreement with Weill Cornell Medicine to expand the use of Nociscan in a study titled “Bone Marrow Aspirate Concentrate Injection with MRI's - a Prospective Randomized Controlled Trial.” https://biotuesdays.com/2026/05/05/aclarion-expands-use-of-nociscan-with-weill-cornell-medicine-commercial-agreement/
1 · Reply
Schizoo
Schizoo May. 5 at 4:31 PM
$ACON
0 · Reply
Schizoo
Schizoo May. 5 at 4:31 PM
$ACON 😘
0 · Reply
Schizoo
Schizoo May. 5 at 4:12 PM
$ACON just start buying back them sharea already! Do something!
0 · Reply